Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with
preserved ejection fraction (HFpEF) has traditionally received less attention than its main …

Background: Cardiometabolic heart failure with preserved ejection fraction (HFpEF) is
largely driven by obesity-related factors, including adipokines and bioactive peptides …

The rising prevalence of cardiovascular (CV) risk factors in Portugal has translated into more
than 35,000 annual deaths due to CV diseases. We performed a multicenter observational …

Chronic kidney disease (CKD) represents a global public health burden, but its true
prevalence is not fully characterized in the majority of countries. We studied the CKD …

It has been a long time since, in the spectrum of ischemic (IHD) or coronary (CHD) heart
diseases, a differentiation was performed between the forms presenting with and those …

Real world data (RWD) and real-world evidence (RWE) plays an increasingly important role
in clinical research since scientific knowledge is obtained during routine clinical large-scale …

Introduction and objectives Heart failure (HF) is a clinical syndrome associated with
substantial morbidity, mortality, and healthcare costs. Dapagliflozin has proven efficacy in …

Цель. Изучить ассоциации повышенного уровня мозгового натрийуретического
пептида (МНУП) и хронической сердечной недостаточности (ХСН) и их вклад в …

Background During the last few years, increasing focus has been placed on heart failure
with mildly reduced ejection fraction (HFmrEF), an intermediate phenotype from preserved to …

Introduction and objectives Current epidemiological data on heart failure (HF) in Portugal
derives from studies conducted two decades ago. The main aim of this study is to determine …